Secreted transforming growth factor β2 activates NF-κB, blocks apoptosis, and is essential for the survival of some tumor cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 101, Issue 18, 2004, Pages 7112-7117

  Lu, Tao ^a   Burdelya, Lyudmila G ^a   Swiatkowski, Shannon M ^a   Boiko, Alexander D ^a   Howe, Philip H ^a   Stark, George R ^a   Gudkov, Andrei V ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

ELISA; Prostate cancer; Smad; Small interfering RNA

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; SMAD2 PROTEIN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA2;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR CELL; WESTERN BLOTTING;

APOPTOSIS; CULTURE MEDIA, CONDITIONED; HUMANS; MALE; NEOPLASMS; NF-KAPPA B; PROSTATIC NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA2; TUMOR CELLS, CULTURED;

EID: 2342510148     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0402048101     Document Type: Article

References (27)

1. Gurova, K. V. & Gudkov, A. V. (2003) J. Cell. Biochem. 88, 128-137.
2. Rayet, B. & Gelinas, C. (1999) Oncogene 18, 6938-6947.
3. Baldwin, A. S. (2001) J. Clin. Invest. 107, 241-246.
4. Karin, M., Cao, Y., Greten, F. R. & Li, Z. W. (2002) Nat. Rev. Cancer 2, 301-310.
5. Massague, J. M. (1998) Annu. Rev. Biochem. 67, 753-791.
6. Govinden, R. & Bhoola, K. D. (2003) Pharmacol. Ther. 98, 257-265.
7. Massague, J. & Chen, Y. G. (2000) Genes Dev. 14, 627-644.
8. Gentry, L. E., Lioubin, M. N., Purchio, A. F. & Marquardt, H. (1988) Mol. Cell. Biol. 8, 4162-4168.
9. Gray, A. M. & Mason, A. J. (1990) Science 247, 1328-1330.
10. Lawrence, D. A. (1996) Eur. Cytokine Network 7, 363-374.
11. Roberts, A. B. (1998) Miner. Electrolyte Metab. 24, 111-119.
12. Gasparian, A. V., Yao, Y. J., Lu, J., Yemelyanov, A. Y., Lyakh, L. A., Slaga, T. J. & Budunova, I. V. (2002) Mol. Cancer Ther. 1, 1079-1087.
13. Sathe, S. S., Sizemore, N., Li, X., Vithalani, K., Commane, M., Swiatkowski, S. M. & Stark, G. R. (2004) Proc. Natl. Acad. Sci. USA 101, 192-197.
14. Kichina, J. V., Rauth, S., Das Gupta, T. K. & Gudkov, A. V. (2003) Oncogene 22, 4911-4917.
15. Myslinski, E., Ame, J. C., Krol, A. & Carbon, P. (2001) Nucleic Acids Res. 29, 2502-2509.
16. Miller, A. D. & Rosman, G. J. (1989) BioTechniques 7, 980-990.
17. Palayoor, S. T., Youmell, M. Y., Calderwood, S. K., Coleman, C. N. & Price, B. D. (1999) Oncogene 18, 7389-7394.
18. Muenchen, H. J., Lin, D. L., Walsh, M. A., Keller, E. T. & Pienta, K. J. (2000) Clin. Cancer Res. 6, 1969-1977.
19. Teicher, B. A., Kakeji, Y., Ara, G., Herbst, R. S. & Northey, D. (1997) In Vivo 11, 453-461.
20. Miagkov, A. V., Kovalenko, D. V., Brown, C. E., Didsbury, J. R., Cogswell, J. P., Stimpson, S. A., Baldwin, A. S. & Makarov, S. S. (1998) Proc. Natl. Acad. Sci. USA 95, 13859-13864.
21. Yoo, J., Ghiassi, M., Jirmanova, L., Balliet, A. G., Hoffman, B., Fornance, A. J., Liebermann, D. A., Bottinger, E. P. & Roberts, A. B. (2003) J. Biol. Chem. 278, 43001-43007.
22. Valderrama-Carvajal, H., Cocolakis, E., Lacerte, A., Lee, E. H., Krystal, G., Ali, S. & Lebrun, J. J. (2002) Nat. Cell Biol. 4, 963-969.
23. Wikstrom, P., Damber, J. & Bergh, A. (2001) Microsc. Res. Tech. 52, 411-419.
24. Han, S. H., Yea, S. S., Jeon, Y. J., Yang, K. H. & Kaminski, N. E. (1998) J. Pharmacol. Exp. Ther. 287, 1105-1112.
25. Arsura, M., Panta, G. R., Bilyeu, J. D., Cavin, L. G., Sovak, M. A., Oliver, A. A., Factor, V., Heuchel, R., Mercurio, F., Thorgeirsson, S. S. & Sonenshein, G. E. (2003) Oncogene 22, 412-425.
26. Sakurai, H., Chiba, H., Sugita, T. & Toriumi, W. (1999) J. Biol. Chem. 274, 30353-30356.
27. Schutte, M. (1999) Ann. Oncol. 10, Suppl. 4, 56-59.